JP2024542840A5 - - Google Patents
Info
- Publication number
- JP2024542840A5 JP2024542840A5 JP2024534140A JP2024534140A JP2024542840A5 JP 2024542840 A5 JP2024542840 A5 JP 2024542840A5 JP 2024534140 A JP2024534140 A JP 2024534140A JP 2024534140 A JP2024534140 A JP 2024534140A JP 2024542840 A5 JP2024542840 A5 JP 2024542840A5
- Authority
- JP
- Japan
- Prior art keywords
- ray powder
- powder diffraction
- solid form
- values
- form according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287212P | 2021-12-08 | 2021-12-08 | |
| US63/287,212 | 2021-12-08 | ||
| PCT/US2022/081060 WO2023107980A1 (en) | 2021-12-08 | 2022-12-07 | Solid state forms of an fgfr inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542840A JP2024542840A (ja) | 2024-11-15 |
| JP2024542840A5 true JP2024542840A5 (https=) | 2025-12-16 |
Family
ID=86731361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534140A Pending JP2024542840A (ja) | 2021-12-08 | 2022-12-07 | Ｆｇｆｒ阻害剤の固体状形態 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250059170A1 (https=) |
| EP (1) | EP4444302A4 (https=) |
| JP (1) | JP2024542840A (https=) |
| KR (1) | KR20240119095A (https=) |
| CN (1) | CN118804748A (https=) |
| AU (1) | AU2022407440A1 (https=) |
| CA (1) | CA3239792A1 (https=) |
| CL (1) | CL2024001679A1 (https=) |
| IL (1) | IL313359A (https=) |
| MX (1) | MX2024006933A (https=) |
| TW (1) | TW202332432A (https=) |
| WO (1) | WO2023107980A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11345681B1 (en) | 2020-06-05 | 2022-05-31 | Kinnate Biopharma Inc. | Inhibitors of fibroblast growth factor receptor kinases |
| AU2022407439A1 (en) * | 2021-12-08 | 2024-06-27 | Kinnate Biopharma Inc. | Treatment of cancer with an fgfr kinase inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10124003B2 (en) * | 2013-07-18 | 2018-11-13 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for FGFR inhibitor-resistant cancer |
| CN107840842A (zh) * | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
| EP3969442A4 (en) * | 2019-05-17 | 2023-08-02 | Kinnate Biopharma Inc. | FIBROBLAST GROWTH FACTOR RECEPTOR KINASE INHIBITORS |
| US11345681B1 (en) * | 2020-06-05 | 2022-05-31 | Kinnate Biopharma Inc. | Inhibitors of fibroblast growth factor receptor kinases |
-
2022
- 2022-12-07 KR KR1020247022100A patent/KR20240119095A/ko active Pending
- 2022-12-07 CA CA3239792A patent/CA3239792A1/en active Pending
- 2022-12-07 US US18/717,390 patent/US20250059170A1/en active Pending
- 2022-12-07 EP EP22905319.4A patent/EP4444302A4/en active Pending
- 2022-12-07 AU AU2022407440A patent/AU2022407440A1/en active Pending
- 2022-12-07 MX MX2024006933A patent/MX2024006933A/es unknown
- 2022-12-07 IL IL313359A patent/IL313359A/en unknown
- 2022-12-07 TW TW111147070A patent/TW202332432A/zh unknown
- 2022-12-07 CN CN202280091311.6A patent/CN118804748A/zh active Pending
- 2022-12-07 JP JP2024534140A patent/JP2024542840A/ja active Pending
- 2022-12-07 WO PCT/US2022/081060 patent/WO2023107980A1/en not_active Ceased
-
2024
- 2024-06-06 CL CL2024001679A patent/CL2024001679A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024026550A5 (https=) | ||
| JP7241916B2 (ja) | ７ｈ－ピロロ［２，３－ｄ］ピリミジンｊａｋ－阻害剤 | |
| JP2024542840A5 (https=) | ||
| JP2023519891A5 (https=) | ||
| JP2025176008A5 (https=) | ||
| TW531527B (en) | Novel Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation | |
| JP2022502500A5 (https=) | ||
| JP2025511847A5 (https=) | ||
| HU223599B1 (hu) | I,II és IV kristályformájú [R-(R*,R*)]-2(4-fluor-fenil)-béta,delta-dihidroxi-5-(1-metil-etil)-3-fenil-4-[(fenil-amino)-karbonil]-1H-pirrol-1-heptánkarbonsav-hemikalciumsó-hidrát (atorvasztatin-hidrát) és a vegyületeket tartalmazó gyógyászati készítmények | |
| JP2018168180A (ja) | バルサルタンおよびａｈｕ−３７７を含む三ナトリウム塩超分子複合体の新規な結晶形及びその製造方法 | |
| JP2022511029A5 (https=) | ||
| JP2022523368A5 (https=) | ||
| JP2022532404A5 (https=) | ||
| JP2025508071A5 (https=) | ||
| JP2024521412A5 (https=) | ||
| JP2025179094A5 (https=) | ||
| JP2025506098A5 (https=) | ||
| TW201514165A (zh) | Ｄ-葡萄糖醇，１-脫氧-１-（甲胺基）-，-１-（６-胺基-３，５-二氟吡啶-２-基）-８-氯-６-氟-１，４-二氫-７-（３-羥基氮雜環丁烷-１-基）-４-側氧基-３-喹啉羧酸的結晶形態與其製備程序 | |
| JP2024547113A5 (https=) | ||
| JPWO2021033729A5 (https=) | ||
| JP2024505063A5 (https=) | ||
| JP2011527687A5 (https=) | ||
| JP2025508069A5 (https=) | ||
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| KR20080078804A (ko) | 이마티니브 메실레이트의 ｆ, ｇ, ｈ, ｉ 및 ｋ 결정형 |